Cargando…
Selection of a novel CD19 aptamer for targeted delivery of doxorubicin to lymphoma cells
CD19 is overexpressed in most human B cell malignancies and considered an important tumor marker for diagnosis and treatment. Aptamers are oligonucleotides that may potentially serve as tumor-homing ligand for targeted cancer therapy with excellent affinity and specificity. In this study, we selecte...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003574/ https://www.ncbi.nlm.nih.gov/pubmed/29928472 http://dx.doi.org/10.18632/oncotarget.24902 |